Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tolvaptan Tablets
DRUG
2 trials
Sponsors
Otsuka Pharmaceutical Development & Commercialization, Inc.
, Institute of Liver and Biliary Sciences, India
Conditions
Autosomal Recessive Polycystic Kidney (ARPKD)
Liver Cirrhosis
Phase 3
A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)
Recruiting
NCT04782258
Otsuka Pharmaceutical Development & Commercialization, Inc.
Autosomal Recessive Polycystic Kidney (ARPKD)
Start: 2023-01-23
End: 2028-08-14
Target: 20
Updated: 2026-02-17
Unknown Phase
To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)
NCT05060523
Institute of Liver and Biliary Sciences, India
Liver Cirrhosis
Start: 2021-09-19
End: 2022-09-30
Target: 220
Updated: 2021-11-29
Related Papers
Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease.
2023-02-13
8 citations